1. Home
  2. ATLX vs FATE Comparison

ATLX vs FATE Comparison

Compare ATLX & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATLX
  • FATE
  • Stock Information
  • Founded
  • ATLX 2011
  • FATE 2007
  • Country
  • ATLX Brazil
  • FATE United States
  • Employees
  • ATLX N/A
  • FATE N/A
  • Industry
  • ATLX Mining & Quarrying of Nonmetallic Minerals (No Fuels)
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ATLX Industrials
  • FATE Health Care
  • Exchange
  • ATLX Nasdaq
  • FATE Nasdaq
  • Market Cap
  • ATLX 111.7M
  • FATE 116.5M
  • IPO Year
  • ATLX N/A
  • FATE 2013
  • Fundamental
  • Price
  • ATLX $6.28
  • FATE $1.57
  • Analyst Decision
  • ATLX Strong Buy
  • FATE Hold
  • Analyst Count
  • ATLX 1
  • FATE 6
  • Target Price
  • ATLX $19.00
  • FATE $3.30
  • AVG Volume (30 Days)
  • ATLX 962.7K
  • FATE 2.8M
  • Earning Date
  • ATLX 11-07-2025
  • FATE 11-11-2025
  • Dividend Yield
  • ATLX N/A
  • FATE N/A
  • EPS Growth
  • ATLX N/A
  • FATE N/A
  • EPS
  • ATLX N/A
  • FATE N/A
  • Revenue
  • ATLX $350,003.00
  • FATE $8,470,000.00
  • Revenue This Year
  • ATLX $22,084.55
  • FATE N/A
  • Revenue Next Year
  • ATLX N/A
  • FATE N/A
  • P/E Ratio
  • ATLX N/A
  • FATE N/A
  • Revenue Growth
  • ATLX N/A
  • FATE N/A
  • 52 Week Low
  • ATLX $3.54
  • FATE $0.66
  • 52 Week High
  • ATLX $11.89
  • FATE $3.50
  • Technical
  • Relative Strength Index (RSI)
  • ATLX 62.90
  • FATE 70.59
  • Support Level
  • ATLX $5.70
  • FATE $0.95
  • Resistance Level
  • ATLX $6.45
  • FATE $1.66
  • Average True Range (ATR)
  • ATLX 0.56
  • FATE 0.14
  • MACD
  • ATLX 0.13
  • FATE 0.06
  • Stochastic Oscillator
  • ATLX 83.77
  • FATE 83.10

About ATLX Atlas Lithium Corporation

Atlas Lithium Corp is a mineral exploration and development company with lithium projects and exploration properties in other critical and battery minerals, including nickel, rare earth, graphite, and titanium, to power the increased demand for electrification. Its focus is on developing its hard-rock lithium project Minas Gerais Lithium Project located in Minas Gerais State in Brazil. The company intends to produce and sell lithium concentrate, a key ingredient for the battery supply chain. It intends to mine and then process its lithium-containing ore to produce lithium concentrate (also known as spodumene concentrate), a key ingredient for the battery supply chain.

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Share on Social Networks: